Abstract
In an effort to develop a sustainable source of podophyllotoxin for the production of anticancer drugs such as etoposide, teniposide and etopophos, Podophyllum peltatum accessions with podophyllotoxin-rich leaf biomass were identified and transplanted to different growing conditions by vegetative cuttings. Results indicate that the lignan profile in leaves does not change over time or due to environment conditions. Podophyllotoxin and α-peltatin content in the blades seems to be stable with an inverse relationship of concentration between these compounds. A podophyllotoxin-rich leaf accession showed low biosynthetic capability to synthesize α- and β-peltatin and the converse was also true, indicating that selection and cultivation of high-yielding podophyllotoxin leaf biomass may reduce production costs.
Key words
Podophyllotoxin -
Podophyllum
- Berberidaceae - etoposide - teniposide - aryltetralin lignans - peltatins
References
1
Imbert T F.
Discovery of podophyllotoxin.
Biochimie.
1998;
80
207-22
2
Stähelin H F, Wartburg A V.
The chemical and biological route form podophyllotoxin glucoside to etoposide: Ninth Cain Memorial Award Lecture.
Cancer Research.
1991;
51
5-15
3
Carlstrom K, Hedin P J, Jansson L, Lerndal T, Lien J, Weitaft T, T.
Axelson T. Endocrine effects of podophyllotoxin derivative drug CPH 82 (Reumacon) in patients with rheumatoid arthritis.
Scandinavian Journal Rheumatology.
2000;
29
89-94
4
Stoerh G P, Peterson A L, Taylor W J.
Systemic complications of local podophyllin therapy.
Annals of Internal Medicine.
1978;
89
362-3
5
Claesson U, Lassus A, Happonen H, Horgström L, Siboulet A.
Topical treatment of venereal warts: a comparative open study of podophyllotoxin cream versus solution.
International Journal of STD and AIDS.
1996;
7
429-34
6
Ajani J D, Mansfield P F, Dumas P.
Oral etoposide from patients with metastatic gastric adenocarcinoma.
Cancer Journal from Scientific American.
1999;
5
112-4
7
Ekstrom K, Hoffman K, Linne T, Eriksoon B, Glimelius B.
Single-dose etoposide in advanced pancreatic and biliary cancer, a phase II study.
Oncology Reports.
1998;
5
931-4
8
Canel C, Moraes R M, Dayan F, Ferreira D.
Podophyllotoxin.
Phytochemistry.
2000;
54
115-20
9
Foster S.
Medicinal plant conservation and generic resources. Examples from the temperate Northern Hemisphere.
Acta Horticulturae.
1993;
330
67-73
10
Bastos J K, Burandt CL J r, Nanayakkara N PD, Bryanat L, McChesney J D.
Quantitation of aryltetralin lignans in plant parts and among different populations of Podophyllum peltatum by reverse-phase high-performance liquid chromatography.
Journal of Natural Products.
1996;
59
406-8
11
Ganzera M, Moraes R M, Khan I.
Separation of Podophyllum lignans by MECC.
Chromatographia.
1999;
49
552-6
12
Moraes-Cerdeira R M, Burandt C LJr, Bastos J K, Nanayakkara N PD, McChesney J D.
In vitro propagation of Podophyllum peltatum
.
Planta Medica.
1998;
23
2-7
13
Canel C, Dayan F, Ganzera M, Burandt C L Jr, Khan I, Moraes R M.
Increased yield of podophyllotoxin form leaves of Podophyllum peltatum L. by in situ conversion of podophyllotoxin glucopyranoside.
Planta Medica.
2000;
67
97-9
14
Moraes R M, Burandt C LJr, Ganzera M, Li X, Khan I, Canel C.
The American Mayapple revisited - Podophyllum peltatum - still a potential cash crop. Economic.
Botany.
2000;
54
471-6
15 SAS copywriting by SAS Institute Inc. 1999 Cary, NC, USA;
16
Jackson D E, Dewick P M.
Tumor-inhibitory aryltetralin lignans from Podophyllum pleianthum
.
Phytochemistry.
1985;
24
2407-9
17
Jackson D E, Dewick P M.
The aryltetralin lignans of Podophyllum hexandrum and Podophyllum peltatum
.
Phytochemistry.
1984;
23
1147-52
18
Christie P J, Alfenito M R, Wlabot V.
Impact of low-temperature stress on general phenyl-propanoid and anthocyanin pathways: Enhancement of transcript abundance and anthocyanin pigmentation in maize seedlings.
Planta.
1994;
194
541-9
19
Grace S C, Logan B A, Adams III W W.
Seasonal differences in foliar content of chlorogenic acid, a phenylpropanoid antioxidant, in Mahonia repens
.
Plant Cell and Environment.
1998;
21
513-21
Rita M. Moraes
NCNPR, School of Pharmacy
The University of Mississippi
University, MS 38677, USA
Telefon: +1 (662) 915 1147
Fax: +1 (662) 915 7989
eMail: rmoraes@olemiss.edu